← FDA Drug Approvals (Drugs@FDA)
DOCETAXEL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN LABS LTD · Approved 2018-07-02
Drug application
- FDA Application #
ANDA210072- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DOCETAXEL
- Generic name
- DOCETAXEL ANHYDROUS
- Active ingredients
- DOCETAXEL
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- MYLAN LABS LTD
- Manufacturer
- Mylan Institutional LLC
- First approval
- 2018-07-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown